AI assistant
GALECTIN THERAPEUTICS INC — Director's Dealing 2015
Jul 8, 2015
33422_dirs_2015-07-08_1c0e5174-7032-4c9b-a16c-c8adbeb74b5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2015-03-12
Reporting Person: FREEMAN KEVIN D (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-12 | Common Stock | A | 11112 | — | Acquired | 17112 | Direct |
| 2015-04-08 | Common Stock | A | 10531 | — | Acquired | 27643 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-08 | Stock Option (right to buy) | $8.10 | D | 14815 | Disposed | 2021-06-02 | Common Stock (14815) | Direct |
Footnotes
F1: Amount reported includes shares acquired on June 1, 2015 and previously reported on a Form 4 filed on June 2, 2015. Shares acquired on June 1, 2015 were originally reported as held indirectly by the reporting person, however, such shares are held directly by the reporting person.
F2: The option vested quarterly in eight equal installments beginning September 2, 2011.
F3: The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 10,531 shares of restricted common stock, reported in Table 1 of this Form 4, as consideration for the cancellation of options granted on June 2, 2011 and March 28, 2013.